Viking Therapeutics (VKTX) Exchange Rate Effect (2022 - 2026)
Viking Therapeutics' (VKTX) quarterly Exchange Rate Effect came in at $16000.0 in Q1 2026, up 1500.0% year-on-year from $1000.0 in Q1 2025, and up 77.78% quarter-over-quarter from $9000.0 in Q4 2025.
Viking Therapeutics (VKTX) Exchange Rate Effect (2022 - 2026) Analysis & Trends
Viking Therapeutics has disclosed Exchange Rate Effect across 5 years of filings, most recently posting $16000.0 for Q1 2026.
- Exchange Rate Effect for Q1 2026 came in at $16000.0, up 1500.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $7000.0 (up 107.07% YoY), and the FY2025 annual result was -$8000.0, up 94.59% from the prior year.
- Exchange Rate Effect came in at $16000.0 for Q1 2026 at Viking Therapeutics, up from $9000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $141000.0 in Q4 2022 to a low of -$223000.0 in Q3 2022.
- The 5-year median for Exchange Rate Effect is -$6000.0 (2025), against an average of -$16800.0.
- Across the five-year window, Exchange Rate Effect sank 500.0% in 2025 and jumped 1500.0% in 2026, its largest moves.
- Viking Therapeutics' Exchange Rate Effect stood at $141000.0 in 2022, then sank by 64.54% to $50000.0 in 2023, then sank by 248.0% to -$74000.0 in 2024, then surged by 112.16% to $9000.0 in 2025, then surged by 77.78% to $16000.0 in 2026.
- The last three Exchange Rate Effect figures came in at $16000.0 (Q1 2026), $9000.0 (Q4 2025), and -$6000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 8.68 Mn |
| 10 | Viking Therapeutics | 3.50 Bn | 3.50 Bn | - | 16,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16,000.00 |
| Mar 31, 2026 | 16,000.00 |
| Dec 31, 2025 | 9,000.00 |
| Dec 31, 2025 | 9,000.00 |
| Sep 30, 2025 | -6,000.00 |
| Sep 30, 2025 | -6,000.00 |
| Jun 30, 2025 | -12,000.00 |
| Jun 30, 2025 | -12,000.00 |
| Mar 31, 2025 | 1,000.00 |
| Mar 31, 2025 | 1,000.00 |
| Dec 31, 2024 | -74,000.00 |
| Dec 31, 2024 | -74,000.00 |
| Sep 30, 2024 | -29,000.00 |
| Sep 30, 2024 | -29,000.00 |
| Jun 30, 2024 | 3,000.00 |
| Jun 30, 2024 | 3,000.00 |
| Mar 31, 2024 | -48,000.00 |
| Mar 31, 2024 | -48,000.00 |
| Dec 31, 2023 | 50,000.00 |
| Dec 31, 2023 | 50,000.00 |